A Phase II Study of TT-01488 Tablets in Combination With Anti-CD20 Monoclonal Antibody Therapy in Patients With Mantle Cell Lymphoma (clinicaltrials.gov) - Oct 3, 2026 - P2 | N=188 | Not yet recruiting | Sponsor: TransThera Sciences (Nanjing), Inc.
New P2 trial • Hematological Malignancies • Lymphoma • Mantle Cell Lymphoma • Oncology • BCL2 • CCND1 • CD20
|